Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Antenatal magnesium sulfate to prevent cerebral palsy
Author: Keir, A.K.
Shepherd, E.
McIntyre, S.
Rumbold, A.
Groves, C.
Crowther, C.
Callander, E.J.
Citation: Archives of Disease in Childhood: Fetal and Neonatal Edition, 2022; 107(2):225-227
Publisher: BMJ Journals
Issue Date: 2022
ISSN: 1359-2998
Statement of
Amy K Keir, Emily Shepherd, Sarah McIntyre, Alice Rumbold, Charlotte Groves, Caroline Crowther, Emily Joy Callander
Abstract: Magnesium sulfate given to women before birth at <30 weeks’ gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks’ gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society.
Keywords: health services research
Description: First published July 7, 2021.
Rights: © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
DOI: 10.1136/archdischild-2021-321817
Grant ID:
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.